Search - tctmd.com

Displaying 761 - 780 of 1865

Sort: Relevancy | Date

Presentation TVT 2019

TAVR Safety in Cancer Including in Metastatic Disease: Propensity Score and Machine Learning Supported Multicenter Case-Control Study of Over 6 Million Hospitalizations

Presenter: Tariq Thannoun

June 14, 2019

Presentation TVT 2019

Future Pillars of Imaging for Structural Heart Disease: 3D Printing and Virtual Reality

Presenter: Dmitry Levin

June 14, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Presentation TVT 2019

Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

Presenter: Vinod Thourani

June 13, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

Presentation TVT 2019

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Calcified Bicuspid Disease) – A Case-Based Discussion

Presenter: Christopher Meduri

June 13, 2019

Presentation TVT 2019

Latest Clinical Data in Bicuspid Disease

Presenter: John Forrest

June 13, 2019

Presentation TVT 2019

Surgery After Failed TAVR: What Does Redo Surgery Look Like in 10 Years? A New Iatrogenic Disease

Presenter: Vinayak Bapat

June 13, 2019

Presentation TVT 2019

Outcomes of Transcatheter Aortic Valve Replacement (TAVR) for Mixed Aortic Valve Disease: Results From the TVT Registry

Presenter: Bhaskar Bhardwaj

June 13, 2019

Presentation TVT 2019

Individualized Care Pathways

Presenter: Sandra Lauck

June 12, 2019

Presentation TVT 2019

Nurse-Led Sedation for TAVR

Presenter: Bria Kneller

June 12, 2019

Presentation TVT 2019

Are There Opportunities in Your Valve Program?

Presenter: Sarah Clarke

June 12, 2019

Presentation TVT 2019

Low-Risk Approval: Who Isn’t a Candidate for TAVR?

Presenter: Tsuyoshi Kaneko

June 12, 2019

News Daily News

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Michael O'Riordan

June 12, 2019

Presentation

TAVR in Patients With End-Stage Renal Disease

June 11, 2019

News Daily News

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Yael L. Maxwell

June 11, 2019

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

News Conference News EAS 2019

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

Michael O'Riordan

June 07, 2019

News Conference News SCAI 2019

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

Yael L. Maxwell

June 05, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

Advertisement

TAVR Safety in Cancer Including in Metastatic Disease: Propensity Score and Machine Learning Supported Multicenter Case-Control Study of Over 6 Million Hospitalizations

Future Pillars of Imaging for Structural Heart Disease: 3D Printing and Virtual Reality

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Calcified Bicuspid Disease) – A Case-Based Discussion

Latest Clinical Data in Bicuspid Disease

Surgery After Failed TAVR: What Does Redo Surgery Look Like in 10 Years? A New Iatrogenic Disease

Outcomes of Transcatheter Aortic Valve Replacement (TAVR) for Mixed Aortic Valve Disease: Results From the TVT Registry

Individualized Care Pathways

Nurse-Led Sedation for TAVR

Are There Opportunities in Your Valve Program?

Low-Risk Approval: Who Isn’t a Candidate for TAVR?

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

TAVR in Patients With End-Stage Renal Disease

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content